At the tumor cell surface thyroid hormone analogue receptor on integrin αvβ3, tetrac inhibits the pro-angiogenic activities of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) [18]. The gene discussed is VEGFA; the disease is neoplasm.